Dimension Therapeutics, Inc. Shareholders' Equity
Dimension Therapeutics, Inc. had Shareholders' Equity of $20.35 million as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2017-11-06
- 2017-09-30: Stockholders' Equity Attributable to Parent $20.35M.
- 2017-06-30: Stockholders' Equity Attributable to Parent $36.07M.
- 2017-03-31: Stockholders' Equity Attributable to Parent $47.49M.
- 2016-12-31: Stockholders' Equity Attributable to Parent $59.94M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2017-09-30 | $20.35M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $36.07M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $47.49M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $59.94M 10-Q · filed 2017-11-06 |
| 2016-09-30 | $72.04M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $85.31M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $96.61M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $105.58M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$39.35M 10-Q · filed 2015-12-04 |
| 2014-12-31 | -$14.19M 10-K · filed 2017-03-09 |
| 2013-12-31 | -$1.28M 10-K · filed 2017-03-09 |